4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-044027
COO & Chief Financial Officer sold 20,000 shares at an average $54.15 ($1,083,074)
- COO & Chief Financial Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LOWE CHRISTOPHER P. · COO & Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 1 in the form | +20,000 | $2.23 | $44,600 | 20,000 | D |
| 2021-06-28 | Sale : show line 2 in the form | −7,724 | $53.39 | $412,384 | 12,276 | D |
| 2021-06-28 | Sale : show line 3 in the form | −7,079 | $54.13 | $383,186 | 5,197 | D |
| 2021-06-28 | Sale : show line 4 in the form | −4,153 | $55.11 | $228,872 | 1,044 | D |
| 2021-06-28 | Sale : show line 5 in the form | −1,044 | $56.16 | $58,631 | 0 | D |
| 2021-06-30 | Exercise or conversion : show line 6 in the form | +30,000 | $2.23 | $66,900 | 30,000 | D |
| Open-market sales · 20,000 sh · avg $54.15 · $1,083,074 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-28 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −20,000 | 215,594 | D |
| 2021-06-30 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −30,000 | 185,294 | D |
Loading xslF345X03/doc4.xml…